ERBB2 and breast carcinoma: The in vitro studies with MDA-MB-231 TNBCs and HER2-positive SK-BR-3 breast cancer cells showed a specific uptake of PTX-ADC and SLM-ADC by bulk tumor cells and CSCs, respectively [109].